SLNB using magnetic and RI methods for oral cancer

Sentinel lymph node biopsy using magnetic method and RI method for oral cancer patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031220038

Enrollment

Registered

2022-04-25

Start date

2023-01-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral cancer oral cancer

Interventions

Superparamagnetic iron oxide and radioisotope are injected around oral cancer 1 day before surgery, and sentinel lymph node mapping is performed using MR lymphography and SPECT/CT. During surgery, sen

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Early stage oral cancer patients without cervical lymph node metastasis (T1-2N0). Untreated oral cancer patients. Written informed consent was obtained.

Exclusion criteria

Exclusion criteria: Patients with iron allergy or pregnancy.

Design outcomes

Primary

Measure	Time frame
Detection rate of sentinel lymph node using magnetic and ganmma probes (Number of patients in whom all sentinel lymph nodes mapped on preoperative images were identified/ all patient number)	—

Secondary

Measure	Time frame
Detection rate of sentinel lymph node using magnetic and ganmma probes (Number of identified lymph node/ total number of mapped lymph node)	—

Contacts

Public ContactToshinori Iwai

Yokohama City University Hospital

iwai104@yokohama-cu.ac.jp+81-45-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026